Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
- PMID: 30332564
- PMCID: PMC6181183
- DOI: 10.1056/NEJMoa1804498
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
Abstract
During 2018, an unusual increase in Lassa fever cases occurred in Nigeria, raising concern among national and international public health agencies. We analyzed 220 Lassa virus genomes from infected patients, including 129 from the 2017-2018 transmission season, to understand the viral populations underpinning the increase. A total of 14 initial genomes from 2018 samples were generated at Redeemer's University in Nigeria, and the findings were shared with the Nigerian Center for Disease Control in real time. We found that the increase in cases was not attributable to a particular Lassa virus strain or sustained by human-to-human transmission. Instead, the data were consistent with ongoing cross-species transmission from local rodent populations. Phylogenetic analysis also revealed extensive viral diversity that was structured according to geography, with major rivers appearing to act as barriers to migration of the rodent reservoir.
Figures


Similar articles
-
Arenavirus Diversity and Phylogeography of Mastomys natalensis Rodents, Nigeria.Emerg Infect Dis. 2016 Apr;22(4):694-7. doi: 10.3201/eid2204.150155. Emerg Infect Dis. 2016. PMID: 26982388 Free PMC article.
-
Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak.Science. 2019 Jan 4;363(6422):74-77. doi: 10.1126/science.aau9343. Science. 2019. PMID: 30606844 Free PMC article.
-
Phylogeography of Lassa Virus in Nigeria.J Virol. 2019 Oct 15;93(21):e00929-19. doi: 10.1128/JVI.00929-19. Print 2019 Nov 1. J Virol. 2019. PMID: 31413134 Free PMC article.
-
Systematics, Ecology, and Host Switching: Attributes Affecting Emergence of the Lassa Virus in Rodents across Western Africa.Viruses. 2020 Mar 14;12(3):312. doi: 10.3390/v12030312. Viruses. 2020. PMID: 32183319 Free PMC article. Review.
-
A short history of Lassa fever: the first 10-15 years after discovery.Curr Opin Virol. 2019 Aug;37:77-83. doi: 10.1016/j.coviro.2019.06.005. Epub 2019 Jul 16. Curr Opin Virol. 2019. PMID: 31323506 Review.
Cited by
-
Distinct Molecular Mechanisms of Host Immune Response Modulation by Arenavirus NP and Z Proteins.Viruses. 2020 Jul 21;12(7):784. doi: 10.3390/v12070784. Viruses. 2020. PMID: 32708250 Free PMC article. Review.
-
Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.Sci Rep. 2020 Sep 29;10(1):16030. doi: 10.1038/s41598-020-72539-w. Sci Rep. 2020. PMID: 32994446 Free PMC article.
-
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics.Wellcome Open Res. 2023 Jun 2;8:122. doi: 10.12688/wellcomeopenres.19041.2. eCollection 2023. Wellcome Open Res. 2023. PMID: 39211525 Free PMC article.
-
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.J Virol. 2019 Apr 3;93(8):e02185-18. doi: 10.1128/JVI.02185-18. Print 2019 Apr 15. J Virol. 2019. PMID: 30700611 Free PMC article.
-
Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice.AIMS Public Health. 2020 Sep 22;7(4):736-757. doi: 10.3934/publichealth.2020057. eCollection 2020. AIMS Public Health. 2020. PMID: 33294478 Free PMC article. Review.
References
-
- Geisbert TW. Predicting outcome and improving treatment for Lassa fever. Lancet Infect Dis 2018;18(6):594–5. - PubMed
-
- WHO. AN R&D BLUEPRINT FOR ACTION TO PREVENT EPIDEMICS. 2016.
-
- WHO. 2018 Annual review of diseases prioritized under the R&D Blueprint [Internet]. 2018. Available from: http://www.who.int/emergencies/diseases/2018prioritization-report.pdf
-
- McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314(1):20–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases